This exciting research from Tel Aviv University confirms several years of work by researchers at the Center for Human Reproduction in New York. Researchers at CHR, knows as the pioneers of DHEA use in increasing female fertility, have been successfully using DHEA to treat diminished ovarian reserve - due to advanced female age or premature ovarian aging - since 2004, and their research has been published in many peer-reviewed medical journals. While Dr. Shulman's study is the first prospectively randomized study on DHEA, Drs. Norbert Gleicher and David H. Barad at CHR have used a multitude of other study designs and have given their clinic a reputation as a "fertility clinic of last resort."